Report

Global Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2022-2029

  • Publish Date: Mar,2023
  • Report ID: 12-2-1016
  • Page : 140
  • Report Type : PDF (Email)
Table of Content:
1. Introduction
1.1. Research Objective
1.2. Research Methodology
1.3. Research Process
1.4. Respondent Profile
2. Executive Summary
3. Global Gene Therapy Market Outlook, 2019-2029F
3.1. Market Size & Analysis
3.2. Market Share & Analysis
3.2.1. By Vector Type
3.2.1.1 Viral Vector
3.2.1.2 Non-Viral Vector
3.2.2. By Therapy
3.2.2.1 In-Vivo Therapy
3.2.2.2 Ex Vivo Therapy
3.2.3. By Gene Type
3.2.3.1. Antigen
3.2.3.2. Cytokine
3.2.3.3. Tumor Suppressor
3.2.3.4. Suicide
3.2.3.5. Deficiency
3.2.3.6. Growth factors
3.2.3.7. Receptors
3.2.3.8. Others
3.2.4. By Application
3.2.4.1. Oncological Disorders
3.2.4.2. Rare Diseases
3.2.4.3. Neurological Disorders
3.2.4.4. Other Diseases
3.2.5. By Region
3.2.5.1. Asia-Pacific
3.2.5.2. Europe
3.2.5.3. North America
3.2.5.4. Middle East & Africa
3.2.5.5. Latin America
4. Asia-Pacific Gene Therapy Market Outlook, 2019-2029F
4.1. Market Size & Analysis
4.2. Market Share & Analysis
4.2.1. By Vector Type
4.2.2. By Therapy
4.2.3. By Gene Type
4.2.4. By Application
4.2.5. By Country
4.2.5.1. China
4.2.5.2. India
4.2.5.3. Japan
4.2.4.4. South Korea
4.2.5.5. Australia
4.2.5.6. Rest of Asia-Pacific
5. Europe Gene Therapy Market Outlook, 2019-2029F
5.1. Market Size & Analysis
5.2. Market Share & Analysis
5.2.1. By Vector Type
5.2.2. By Therapy
5.2.3. By Gene Type
5.2.4. By Application
5.2.5. By Country
5.2.5.1. United Kingdom
5.2.5.2. Germany
5.2.5.3. France
5.2.5.4. Italy
5.2.5.5. Russia
5.2.5.6. Rest of Europe
6. North America Gene Therapy Market Outlook, 2019-2029F
6.1. Market Size & Analysis
6.2. Market Share & Analysis
6.2.1. By Vector Type
6.2.2. By Therapy
6.2.3. By Gene Type
6.2.4. By Application
6.2.5. By Country
6.2.5.1. United States
6.2.5.2. Canada
7. Latin America Gene Therapy Market Outlook, 2019-2029F
7.1. Market Size & Analysis
7.2. Market Share & Analysis
7.2.5. By Vector Type
7.2.5. By Therapy
7.2.4. By Gene Type
7.2.5. By Application
7.2.5. By Country
7.2.5.1. Brazil
7.2.5.2. Mexico
7.2.5.3. Rest of Latin America
8. Middle East & Africa Gene Therapy Market Outlook, 2019-2029F
8.1. Market Size & Analysis
8.2. Market Share & Analysis
8.2.1. By Vector Type
8.2.2. By Therapy
8.2.3. By Gene Type
8.2.4. By Application
8.2.5. By Country
8.2.5.1. Saudi Arabia
8.2.5.2. UAE
8.2.5.3. South Africa
8.2.5.4. Rest of Middle East and Africa
9. Global Gene Therapy Market Dynamics
9.1. Growth Drivers
9.2. Challenges
9.3. Impact Analysis
10. Global Gene Therapy Market Opportunities
11. Global Sports Medicine Value Chain Analysis
12. Global Gene Therapy Market Policies and Regulations
13. Global Gene Therapy Market Trends & Insights
14. Global Gene Therapy Market Porters Five Forces Analysis
15. Global Gene Therapy Market-Entropy
15.1. New Vector Type Launches
15.2. M&A, Collaborations, JVs, and Partnerships
16. Global Gene Therapy Market Company Analysis
16.1. Amgen Inc.
16.2 Biogen Inc.
16.3 Bluebird Bio Inc.
16.4 Gilead Sciences Inc. (Kite Pharma)
16.5 Novartis AG
16.6 F. Hoffmann-La Roche Ltd (Spark Therapeutics)
16.7 UniQure NV
16.8 Abeona Therapeutics Inc.
16.9 Generation Bio
16.10 Poseida Therapeutics
17. About Us & Contact Details